Ep 64: Guest Clare Turnbull Part 2
Melanoma Matters24 Mar 2025

Ep 64: Guest Clare Turnbull Part 2

In this episode of Melanoma Matters, hosts James Larkin and Sapna Patel pick up with Part 2 of 2 - a deep conversation with Claire Turnbull - about the complexities of cancer screening, overdiagnosis, and the role of genetic testing. They explore the implications of screening practices illustrated by the Gilbert Welch paradigm, the challenges faced in patient management, and the future of genetic testing in oncology. The discussion emphasizes the importance of understanding the risks and benefits associated with genetic testing.

Keywords

melanoma, cancer screening, overdiagnosis, genetic testing, patient management, healthcare, public health, cancer research, screening guidelines, cancer predisposition


Takeaways

• The conversation highlights the importance of understanding the value of cancer screening.

• Overdiagnosis is a significant concern in cancer screening practices.

• Genetic testing plays a crucial role in identifying cancer predisposition.

• Screening should be evaluated rigorously to ensure it benefits patients.

• The implications of false positives in screening can lead to unnecessary anxiety for patients.

• Healthcare providers must be responsible for interpreting test results they order.

• The need for genetic counseling is critical in managing test results and patient care.

• There is a growing concern about the overuse of broad genetic testing panels.

• Future advancements in technology may improve screening methods.

• Public health messaging must address the complexities of cancer screening and genetic testing.


Chapters

00:00 Clare Turnbull - Part 2 of 2

04:05 High penetrance, common SNPs, and in betweens

07:15 The Gilbert Welch Paradigm

12:30 Understanding Lead Time and Overdiagnosis

16:11 Randomized Trials in Screening

19:59 Consequences of Screening: Overdiagnosis and Anxiety

22:22 Debate on Screening Protocols and Their Efficacy

25:37 Need for Evidence-Based Genetic Testing

31:19 Ripple Effects of Genetic Testing on Families

34:00 Fact Check

35:47 Genetic testing for ACC?!

36:34 Clinical Genetics clinics are NOT just reading guidelines...

39:52 David Sackett: Evidence-Based Medicine

43:03 Triggering James: (S)he who orders the test reviews & interprets the test



Episoder(84)

Ep 81: IGNYTE trial (RP1 + nivo)

Ep 81: IGNYTE trial (RP1 + nivo)

SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into cli...

13 Feb 32min

Ep 80: 2025 Holiday Special

Ep 80: 2025 Holiday Special

SummaryHappy Holidays and Festive Season Everyone! In this episode of Melanoma Matters, hosts Sapna Patel and James reflect on their "cultural" experiences over the past year, discussing movies, music...

30 Des 202535min

Ep 79: coBRIM, COMBI-d 5-year follow-up

Ep 79: coBRIM, COMBI-d 5-year follow-up

SummaryIn this episode of Melanoma Matters, James awaits an invitation to a film premiere (The Penguin Lessons) and we all await a picture of him in his tuxedo! Sapna and James go on to discuss the 5-...

29 Des 202536min

Ep 78 TRAILER: MEK inhibitor trials

Ep 78 TRAILER: MEK inhibitor trials

Enjoy this short trailer on MEK inhibitor monotherapy trials in melanoma

29 Des 20251min

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

SummarySo many shoutouts in this episode of Melanoma Matters! Sapna and James engage in a lively discussion about MEK inhibitors as monotherapy treatment. They explore the METRIC, NEMO, and pimasertib...

29 Des 202537min

Ep 77: Guest Merrick Ross

Ep 77: Guest Merrick Ross

SummaryIn this episode of Melanoma Matters, hosts James Larkin and Sapna Patel engage with Merrick Ross, a seasoned surgical oncologist, discussing his background, the evolution of surgical practice w...

29 Des 202544min

Ep 76: KEYNOTE 054 7-year follow-up

Ep 76: KEYNOTE 054 7-year follow-up

SummaryIn this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054There's a bit too...

28 Des 202528min

Ep 75: Immune-mediated Myocarditis

Ep 75: Immune-mediated Myocarditis

SummaryIn this (longest to-date) episode, James and Sapna delve into the not-so-rare occurence of immune-mediated myocarditis, particularly in the context of immune checkpoint inhibitors. The hosts di...

28 Des 20251h 4min

Populært innen Helse

fastlegen
rss-gukild-johaug
lydartikler-fra-aftenposten
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-garne-damer
foreldreradet
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
morten-ramm-lar-kakla-ga-til-du-sovner
rss-lopedrommen
hormonelle-frida
klimaks
hjernesterk
rss-femihelse
g-punktet
rss-sunn-okonomi
treningsprat
rss-skravla-gar